Generate a tailored SOP for Dr. Ingo Mellinghoff. Improve your application with a focused, well-structured draft.
Ingo K. Mellinghoff, MD, FACP, is a leading researcher in the study of molecular pathways that regulate brain tumor growth. He focuses on developing therapeutic paradigms that target specific properties of primary brain tumors, including genetic alterations in cancer signaling pathways and unique aspects of brain tumor metabolism. His research emphasizes the interactions between brain tumor cells and their microenvironment. Mellinghoff’s studies utilize experimental brain tumor models that are closely linked to the evaluation of novel agents in early-phase clinical trials. His work has contributed to advancements in understanding low-grade gliomas and related brain tumors, leading to new treatment options. As the Chair of the Department of Neurology at Memorial Sloan Kettering Cancer Center, he directs a lab committed to innovative research aimed at improving outcomes for patients with brain cancer.
Memorial Sloan Kettering Cancer Center • New York, NY
Leads the Department of Neurology and oversees research and clinical activities related to brain tumors.
Administered through the Gerstner Sloan Kettering (GSK) Graduate School. The program focus is Cancer Biology and includes faculty from the Department of Molecular Pharmacology.